Incidence of respiratory syncytial virus infection in children with congenital heart disease undergoing immunoprophylaxis with palivizumab in Pará state, north region of Brazil

BACKGROUND: Palivizumab prophylaxis for the human respiratory syncytial virus (HRSV) has been reported to reduce the risk of hospital admissions related to HRSV in children with congenital heart disease (CHD). These children are at high risk of developing severe lower respiratory tract infection (LR...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Pediatr
Main Authors: de Souza, Roseane Porfírio, Ribeiro, Andre Luis Ribeiro, de Menezes, Sílvio Augusto Fernandes, Machado, Luiz Fernando Almeida
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6714430/
https://ncbi.nlm.nih.gov/pubmed/31462289
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12887-019-1681-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados